Medrix Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-12-2024
- Paid Up Capital ₹ 1.00 M
as on 07-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 M
as on 07-12-2024
- Revenue %
(FY 2022)
- Net Worth 659.40%
(FY 2022)
- Total Assets 77.98%
(FY 2022)
About Medrix Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rohit Sharma and Karamjit serve as directors at the Company.
- CIN/LLPIN
U24290PB2020PTC051613
- Company No.
051613
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Patiala, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medrix Labs Private Limited offer?
Medrix Labs Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Digestive System Drugs & Medicines, Antispasmodic Drugs, Respiratory System Drugs, Anti Asthma Drug, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Antidiabetic Medicine, Common Disease Medicines.
Who are the key members and board of directors at Medrix Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Sharma  | Director | 11-Aug-2020 | Current |
| Karamjit | Director | 11-Aug-2020 | Current |
Financial Performance of Medrix Labs.
Medrix Labs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 659.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medrix Labs?
In 2022, Medrix Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹0
₹1.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2022 | State Bank Of India | ₹1.00 M | Satisfied |
How Many Employees Work at Medrix Labs?
Medrix Labs has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medrix Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medrix Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.